noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

U.S. Southern Command

Trinidad and Tobago's Prime Minister Kamla Persad-Bissessar visits SOUTHCOM
Hawaii Department of Transportation

Early 2026 traffic deaths
United States Attorney's Office[...]

Georgia Man Charged with Transmitting Threat to South Florida Victim

Healthcare

Akari Therapeutics plc

10/15/2025 | Press release | Distributed by Public on 10/15/2025 06:46

Regulation FD Disclosure (Form 8-K)

Item 7.01 Regulation FD Disclosure.

On October 15, 2025, Akari Therapeutics, Plc (the "Company") issued a press release announcing titled "Akari Therapeutics Announces $2.5 Million Registered Direct Offering". The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information reported under Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1, is being "furnished" and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Akari Therapeutics plc published this content on October 15, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on October 15, 2025 at 12:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]